BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 16624531)

  • 1. Three dimensions of clinical symptoms in elderly patients with schizophrenia: prediction of six-year cognitive and functional status.
    Chemerinski E; Reichenberg A; Kirkpatrick B; Bowie CR; Harvey PD
    Schizophr Res; 2006 Jul; 85(1-3):12-9. PubMed ID: 16624531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Psychopathologic and cognitive investigations in schizophrenia].
    Farkas M
    Orv Hetil; 2009 Mar; 150(9):423-9. PubMed ID: 19228571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive insight and its relationship with symptoms in deficit and nondeficit schizophrenia.
    Ekinci O; Albayrak Y; Ekinci A
    J Nerv Ment Dis; 2012 Jan; 200(1):44-50. PubMed ID: 22210361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of the Alzheimer's Disease Assessment Scale-Cognitive (ADAS-Cog) in an Icelandic elderly population.
    Hannesdóttir K; Snaedal J
    Nord J Psychiatry; 2002; 56(3):201-6. PubMed ID: 12079572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Insight and social functioning in deficit and nondeficit schizophrenia].
    Köşger F; Şahin H; Eşsizoğlu A; Aksaray G
    Turk Psikiyatri Derg; 2014; 25(3):157-62. PubMed ID: 25219689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.
    Mavioglu H; Gedizlioglu M; Akyel S; Aslaner T; Eser E
    Int J Geriatr Psychiatry; 2006 Mar; 21(3):259-65. PubMed ID: 16477580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for the deficit syndrome of schizophrenia.
    Kirkpatrick B; Castle D; Murray RM; Carpenter WT
    Schizophr Bull; 2000; 26(1):233-42. PubMed ID: 10755684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of mild cognitive impairment in Chinese older adults--a multistage validation of the Chinese abbreviated mild cognitive impairment test.
    Lam LC; Tam CW; Lui VW; Chan WC; Chan SS; Chiu HF; Leung T; Tham MK; Ho KS; Chan WM
    Neuroepidemiology; 2008; 30(1):6-12. PubMed ID: 18204291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reexamination of the characteristics of the deficit schizophrenia patients.
    Tiryaki A; Yazici MK; Anil AE; Kabakçi E; Karaağaoğlu E; Göğüş A
    Eur Arch Psychiatry Clin Neurosci; 2003 Oct; 253(5):221-7. PubMed ID: 14504990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging.
    Friedman JI; Harvey PD; Coleman T; Moriarty PJ; Bowie C; Parrella M; White L; Adler D; Davis KL
    Am J Psychiatry; 2001 Sep; 158(9):1441-8. PubMed ID: 11532729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychopathology and neuropsychological impairments in deficit and nondeficit schizophrenia of Chinese origin.
    Wang X; Yao S; Kirkpatrick B; Shi C; Yi J
    Psychiatry Res; 2008 Mar; 158(2):195-205. PubMed ID: 18243336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complex activities of daily living in mild cognitive impairment: conceptual and diagnostic issues.
    Perneczky R; Pohl C; Sorg C; Hartmann J; Komossa K; Alexopoulos P; Wagenpfeil S; Kurz A
    Age Ageing; 2006 May; 35(3):240-5. PubMed ID: 16513677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting treatment effects with combinations of the ADAS-cog items in patients with mild and moderate Alzheimer's disease.
    Ihl R; Ferris S; Robert P; Winblad B; Gauthier S; Tennigkeit F
    Int J Geriatr Psychiatry; 2012 Jan; 27(1):15-21. PubMed ID: 21384431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alexithymia in negative symptom and non-negative symptom schizophrenia].
    Nkam I; Langlois-Thery S; Dollfus S; Petit M
    Encephale; 1997; 23(5):358-63. PubMed ID: 9453928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive assessment of geriatric schizophrenic patients with severe impairment.
    Bowie CR; Harvey PD; Moriarty PJ; Parrella M; White L; Mohs RC; Davis KL
    Arch Clin Neuropsychol; 2002 Oct; 17(7):611-23. PubMed ID: 14591846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severity of symptoms in chronically institutionalized geriatric schizophrenic patients.
    Davidson M; Harvey PD; Powchik P; Parrella M; White L; Knobler HY; Losonczy MF; Keefe RS; Katz S; Frecska E
    Am J Psychiatry; 1995 Feb; 152(2):197-207. PubMed ID: 7840352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Summer birth and deficit schizophrenia in Dumfries and Galloway, southwestern Scotland.
    Kirkpatrick B; Tek C; Allardyce J; Morrison G; McCreadie RG
    Am J Psychiatry; 2002 Aug; 159(8):1382-7. PubMed ID: 12153832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A five-year followup study of deficit and nondeficit schizophrenia.
    Tek C; Kirkpatrick B; Buchanan RW
    Schizophr Res; 2001 Apr; 49(3):253-60. PubMed ID: 11356586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.